Skip to main content

Find Clinical Trials

Home
Conditions
Adrenal Gland Neoplasms

Clinical trial condition

Adrenal Gland Neoplasms

Explore clinical trials studying Adrenal Gland Neoplasms. Study availability and eligibility vary by location and protocol.

85 public trials 24 recruiting studies

Refine in advanced search Browse all conditions

Adrenal Gland Neoplasms trial results

Active, Not Recruiting

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

NCT03604198

Conditions: ACTH Syndrome, Ectopic, Adenocarcinoma, Adrenal Cortex Diseases, +30 more
Locations: Site 49 Phoenix, Arizona, United States

Site 35 Stanford, California, United States

Site 39 Torrance, California, United States

Site 50 Miami, Florida, United States

View all 48 locations

View Trial Details

Active, Not Recruiting

Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma

NCT02673333

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations: University of Michigan (Data or Specimen Analysis Only) Ann Arbor, Michigan, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)

NCT04358107

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

NCT03833700

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +30 more
Locations: Eisai Trial Site#7 Nagoya, Aichi-ken, Japan

Eisai Trial Site #2 Kashiwa, Chiba, Japan

Eisai Trial Site #5 Sapporo, Hokkaido, Japan

Eisai Trial Site#8 Sendai, Miyagi, Japan

View Trial Details

Active, Not Recruiting

Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma

NCT05036434

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations: National Cancer Center Goyang-si, Gyeonggi-do, South Korea

View Trial Details